Search
for
Sort by
Research 241–270 of 1000+
- HAIR LOSS ASSOCIATED WITH ESCITALOPRAM: DO SSRIs AFFECT MELATONIN AT THE HAIR FOLLICLE?
- ALOPECIA AREATA IN INFANTS: IS IT UNCOMMON?
- 9. Immunology and Genetics
- Skin Conditions in Figure Skaters, Ice-Hockey Players and Speed Skaters
- Dermatoses of pregnancy
- Kids are not just little people: Pediatric versus adult dermatology approaches to skin diseases. Part I
- Cicatricial Alopecias
- Psoriasis and Alopecia: Unveiling the Links
- Telogen Effluvium
- Telogen Effluvium Caused by Magnesium Valproate and Lamotrigine
- Alopecias
- Primary cicatricial alopecia
- Acquired scalp alopecia. Part I: A review
- Pregnancy and Skin
- Evaluation of hair loss
- Scarring Alopecia
- Drug-Induced Hair Changes
- Prolonged Drug-Induced Hypersensitivity Syndrome/DRESS With Alopecia Areata and Autoimmune Thyroiditis
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Black Hairy Tongue After Allogeneic Stem Cell Transplantation: An Unrecognized Cutaneous Presentation of Graft-Versus-Host Disease
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Nodular-cystic eruption in course of sorafenib administration for hepatocarcinoma: An unconventional skin reaction requiring unconventional treatment
- A rare complication of follicular hair unit extraction: Kaposi’s varicelliform eruption
- Epidermal Growth Factor Receptor Inhibitors: Cutaneous Side Effects and Their Management.
- Confirmation of Metformin-Induced Acute Generalized Exanthematous Pustulosis Through a Positive Dechallenge-Rechallenge Test: A Case Report and Review of Cutaneous Manifestations Associated With Metformin
- Psychotropic Medications and the Skin
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Cutaneous Lesions in the Rat Following Administration of an Irreversible Inhibitor of erbB Receptors, Including the Epidermal Growth Factor Receptor
- Hair eruption initiates and commensal skin microbiota aggravate adverse events of anti-EGFR therapy
- Lenalidomide for refractory cutaneous manifestations of pediatric systemic lupus erythematosus